Hemay808

DRUG2 trials

Sponsors

Tianjin Hemay Pharmaceutical Co., Ltd

Conditions

Atopic DermatitisSafety Issues

Phase 1

A Phase I Clinical Study of Hemay808

CompletedNCT04100642

Tianjin Hemay Pharmaceutical Co., LtdSafety Issues

Start: 2019-04-08End: 2019-12-22Updated: 2020-04-27

Phase 2

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

CompletedNCT04352595

Tianjin Hemay Pharmaceutical Co., LtdAtopic Dermatitis

Start: 2020-04-24End: 2021-04-02Updated: 2024-03-01